Prabalini Rajendram, MD

Prabalini Rajendram, MD
  • No ratings
  • 0 Patient Satisfaction Ratings
  • 0 Patient Comments
Department Critical Care Medicine
Primary Location Cleveland Clinic Main Campus
Type of Doctor Adults Only
Languages English
Surgeon No
Cleveland Clinic Main Campus
Primary Location

Cleveland Clinic Main Campus


Additional Locations



Is Cleveland Clinic Part of Your Insurance?

Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.

View All Plans

About Prabalini Rajendram, MD

Dr. Prabalini Rajendram is a Medical Critical Care Physician and Clinical Assistant Professor of Cleveland Clinic Lerner College of Medicine (CCLCM) of Case Western Reserve University (CWRU). In 2013, she was appointed to the Professional Staff in the Department of Critical Care Medicine in the Respiratory Institute at Cleveland Clinic.

Dr. Rajendram received her medical degree from St. George’s School of Medicine in Grenada. She completed her Internal Medicine residency at Lenox Hill Hospital in New York, NY and her Critical Care Fellowship at Memorial Sloan Kettering Cancer Center in New York, NY. She is board certified in Internal Medicine and Critical Care Medicine. Dr. Rajendram is an active member of the Society of Critical Care Medicine, American Thoracic Society and American College of Chest Physicians.

Dr. Rajendram has a strong interest in Interprofessional education. She is the Co-Director of Interprofessional Scholars Collaboration in Teaching and Learning at CWRU and Associate Director of Interprofessional Education at CCLCM where she serves on the Foundations of Clinical Medicine Committee, IPE Steering Committee, and Curriculum Steering Council. She is a member of the Cleveland Clinic Pulmonary Critical Care Fellowship Clinical Competency Committee and the leader for Cleveland Clinic’s physician onboarding series To Act as a Unit; Professionalism course.

Dr. Rajendram’s professional service goals have been concentrated on clinical ethics and interprofessional collaboration. She has published four peer reviewed research articles, presented several abstracts at national meetings on various topics in Critical Care Medicine and collaborated with Cleveland Clinic’s Department of Bioethics to speak at international conferences.

Dr. Rajendram resides in Cleveland, Ohio.

Education & Professional Highlights

Education & Professional Highlights


Education & Fellowships

Fellowship - Memorial Sloan Kettering Cancer Center
Critical Care Medicine
New York, NY USA

Residency - Lenox Hill Hospital
Internal Medicine
New York, NY USA

Medical Education - St. George's University School of Medicine
Grenada, West Indies

Undergraduate - Virginia Commonwealth University
Richmond, VA USA


  • Internal Medicine
  • Internal Medicine - Critical Care Medicine

Specialty Interests

Ultrasonography use in ICU Ethical Issues and End of Life in ICU Physician Communication

Research & Publications

Research & Publications

See publications for Prabalini Rajendram, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Industry Relationships

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 1/18/2020, Dr. Rajendram has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Related Videos Featuring Prabalini Rajendram, MD

Related Videos Featuring Prabalini Rajendram, MD

Back to Top